Testing effectiveness (Phase 2)UnknownNCT02935517
What this trial is testing
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
Who this might be right for
Achromatopsia
Beacon Therapeutics 24